Weir MR, Gogate J, Damaraju CV, Correa-Rotter R, et al. Effects of canagliflozin on major adverse cardiovascular events by baseline estimated glomerular filtration rate: Pooled Hispanic subgroup analyses from the CANVAS Program and CREDENCE trial. Diabetes Obes Metab 2022;24:12-20.
PMID: 34463423